Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Inflammations
ADR ID BADD_A02310
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.05      Inflammations
Description A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. [MeSH]
MedDRA Code 10021950
MeSH ID D007249
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Inflammation | Inflammations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02365Vismodegib0.000381%
BADD_D02369Voriconazole--
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02383Zidovudine--
BADD_D02392Zoledronic acid0.126541%
BADD_D02407Upadacitinib0.001881%
BADD_D02412Octreotide0.000466%
BADD_D02423Fondaparinux0.004934%
BADD_D02450Crisaborole0.004008%
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.006365%
BADD_D02470Nintedanib0.000336%
BADD_D02473Sodium chloride0.000603%
BADD_D02483Ribociclib0.000168%
BADD_D02487Baricitinib0.001061%
BADD_D02492Deflazacort0.000117%
BADD_D02498Abemaciclib0.000437%
BADD_D02504Lorlatinib0.000302%
BADD_D02511Siponimod--
BADD_D02539Calcium0.000391%
BADD_D02558Gadolinium cation (3+)-
BADD_D02567Lutetium lu-177 vipivotide tetraxetan-
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02586Radium ra-223 dichloride-
BADD_D02591Ripretinib0.000246%
BADD_D02597Tapinarof-
BADD_D02634Rolitetracycline--
BADD_D02635Rupatadine--
BADD_D02641Xylometazoline--
The 14th Page    First    Pre   14    Total 14 Pages